UROY(UROY)
UROY
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $68M | $45M |
| Low | $68M | $45M |
| High | $68M | $45M |
| EBITDA Avg | $12M | $8M |
| Low | $12M | $8M |
| High | $12M | $8M |
| EBIT Avg | $11M | $8M |
| Low | $11M | $8M |
| High | $11M | $8M |
| Net Income Avg | $497,159 | $-4M |
| Low | $497,159 | $-4M |
| High | $497,159 | $-4M |
| EPS Avg | $0.00 | $-0.03 |
| Low | $0.00 | $-0.03 |
| High | $0.00 | $-0.03 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|
| Revenue Avg | $237M | $255M | $274M |
| Low | $237M | $255M | $274M |
| High | $237M | $255M | $274M |
| EBITDA Avg | $40M | $43M | $46M |
| Low | $40M | $43M | $46M |
| High | $40M | $43M | $46M |
| EBIT Avg | $40M | $43M | $46M |
| Low | $40M | $43M | $46M |
| High | $40M | $43M | $46M |
| Net Income Avg | $994,319 | $994,319 | $994,319 |
| Low | $994,319 | $994,319 | $994,319 |
| High | $994,319 | $994,319 | $994,319 |
| EPS Avg | $0.01 | $0.01 | $0.01 |
| Low | $0.01 | $0.01 | $0.01 |
| High | $0.01 | $0.01 | $0.01 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |